Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 10/20 | 0.82 |
| ▸ | MAPT | P10636 | 4/20 | 0.71 |
| ▸ | MEN1 | O00255 | 4/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.71 |
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
| ▸ | HTT | P42858 | 2/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | RECQL | P46063 | 1/20 | 0.71 |
| ▸ | BLM | P54132 | 1/20 | 0.71 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.71 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.71 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29564125 | 1.00 | FTO (0.82) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL6429118 | 0.95 | FTO (0.75) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL29413057 | 0.90 | FTO (1.00) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL220211 | 0.90 | FTO (1.00) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL1539098 | 0.90 | FTO (0.81) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL12203251 | 0.90 | FTO (0.85) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL27920238 | 0.89 | FTO (0.97) | FTOMAPTMEN1KMT2AHPGD | |
| Fluorescein SCHEMBL8697200 | 0.88 | FTO (0.87) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL10900216 | 0.87 | FTO (0.92) | FTOMAPTMEN1KMT2AHPGD | |
| SCHEMBL23352978 | 0.86 | FTO (0.62) | FTOMAPTMEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 463 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118518884-A | Functionalized magnetic microsphere and application thereof in troponin immunodetection | 山东交通学院 | 2024-08-20 | — | — | CN | claimed |
| CN-113117172-B | Blood simulation medium and preparation method and application thereof | 佛山市博新生物科技有限公司 | 2024-06-11 | — | — | CN | claimed |
| CN-115785117-B | Compound, kit and application of compound serving as photomagnetic bimodal probe | 北京大学第三医院（北京大学第三临床医学院） | 2024-06-11 | — | — | CN | claimed |
| EP-3554526-B1 | LUTEINIZING HORMONE-RELEASING HORMONE RECEPTOR (LHRH-R) CONJUGATES AND USES THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2024-05-08 | — | — | EP | claimed |
| US-11883498-B2 | Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof | PURDUE RESEARCH FOUNDATION (US) | 2024-01-30 | — | — | US | claimed |
| CN-114813689-B | Method for analyzing absorption capacity of hyaluronic acid penetrating membrane | 梅晔生物医药股份有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-116718644-A | Carbon dioxide sensor material and device based on ion conduction gain effect | 华南师范大学 | 2023-09-08 | — | — | CN | claimed |
| CN-115785117-A | Compound, kit and application of compound and kit as photomagnetic bimodal probe | 北京大学第三医院（北京大学第三临床医学院） | 2023-03-14 | — | — | CN | claimed |
| CN-114813689-A | Method for analyzing absorption capacity of hyaluronic acid penetrating cell membrane | 梅晔生物医药股份有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-110643032-B | Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance | 厦门赛诺邦格生物科技股份有限公司 | 2022-01-28 | — | — | CN | claimed |
| US-6812036-B2 | DETECTING PREFERENTIAL COMPOUNDS IN CEREALS; OBTAIN CEREAL SAMPLE, MIX WITH TRACER, DETECT ADJUSTMENT IN FLUORESCENCE POLARIZATION, COMPARE TO CONTROL, MEASURE CONCENTRATION OF PREFERENTIAL PARTICLES | DIACHEMIX LLC | 2004-11-02 | — | — | US | claimed |
| US-20040214199-A1 | Triphosphate oligonucleotide modification reagents and uses thereof | AUDAX PRIVATE DEBT LLC, AS AGENT | 2004-10-28 | — | — | US | claimed |
| EP-1320755-A2 | FLUORESCENCE POLARIZATION-BASED HOMOGENEOUS ASSAY FOR DEOXYNIVALENOL DETERMINATION IN GRAINS | Diachemix LLC (US) | 2003-06-25 | — | — | EP | claimed |
| EP-1305327-A2 | TRIPHOSPHATE OLIGONUCLEOTIDE MODIFICATION REAGENTS AND USES THEREOF | Schwartz, David A. (US) | 2003-05-02 | — | — | EP | claimed |
| US-20020055180-A1 | Fluorescence polarization-based homogeneous assay for deoxynivalenol determination in grains | DIACHEMIX LLC | 2002-05-09 | — | — | US | claimed |
| WO-2002023196-A2 | FLUORESCENCE POLARIZATION-BASED HOMOGENEOUS ASSAY FOR DEOXYNIVALENOL DETERMINATION IN GRAINS | DIACHEMIX LLC (US) | 2002-03-21 | — | — | WO | claimed |
| WO-2002010432-A2 | TRIPHOSPHATE OLIGONUCLEOTIDE MODIFICATION REAGENTS AND USES THEREOF | SCHWARTZ DAVID A (US) | 2002-02-07 | — | — | WO | claimed |
| EP-0745602-A1 | Quinidine immunoassay and reagents | F. HOFFMANN-LA ROCHE AG (CH) | 1996-12-04 | — | — | EP | claimed |
| EP-0371253-B1 | Method and reagents for detecting amphetamine and/or d-methamphetamine in biological samples | ABBOTT LAB (US) | 1995-09-13 | — | — | EP | claimed |
| US-5099020-A | Immunoassay with fluorescent compounds | ABBOTT LABORATORIES (US) | 1992-03-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214199-A1 | Triphosphate oligonucleotide modification reagents and uses thereof | RNGTT, DUT, NUDT1 | FTO 307/4885MAPT 4128/4885MEN1 4429/4885 |
| US-11883498-B2 | Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof | GNRHR, LHCGR, GHRHR | FTO 2148/4885MAPT 2652/4885MEN1 324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.